 NEW YORK, July 06, 2021 GLOBE NEWSWIRE -- Protagenic Therapeutics, Inc. Nasdaq: PTIX a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders, today announced that it will host a key opinion leader KOL webinar focused on PT00114 for the regulation of stress in patients with Depression, PTSD, Anxiety and Addiction on Tuesday, July 13 at 10:00AM ET. 